TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer

Expression pattern and biological roles of TRIM22 remains unknown in most human cancers. The present study aims to discover its clinical significance and function in human non-small cell lung cancer (NSCLC). Immunohistochemistry was used to examine TRIM22 expression in 126 cases of NSCLC specimens....

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Li, Zhou, Xiao-Ming, Yang, Fang-Fei, Miao, Yuan, Yin, Yan, Hu, Xue-Jun, Hou, Gang, Wang, Qiu-Yue, Kang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617487/
https://www.ncbi.nlm.nih.gov/pubmed/28977927
http://dx.doi.org/10.18632/oncotarget.18911

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5617487/
https://www.ncbi.nlm.nih.gov/pubmed/28977927
http://dx.doi.org/10.18632/oncotarget.18911

Ejemplares similares